| 2011 | | Fat redistribution preferentially reflects the anti-inflammatory benefits of pioglitazone treatment. | 김혜진 |
| 2011 | | Fermented kimchi reduces body weight and improves metabolic parameters in overweight and obese patients. | 김대중, 김혜진, 안소연, 이관우, 이민석, 한승진 |
| 1997 | | Gain or loss of diabetogenicity resulting from a single point mutation in recombinant encephalomyocarditis virus. | 강엽, 윤지원 |
| 2014 | | Glycaemic and haemoglobin A1c thresholds for detecting diabetic retinopathy: the fifth Korea National Health and Nutrition Examination Survey (2011). | 김대중 |
| 2015 | | Improvement of Nonalcoholic Fatty Liver Disease With Carnitine-Orotate Complex in Type 2 Diabetes (CORONA): A Randomized Controlled Trial. | 이관우 |
| 2017 | | Incidence and predictors of type 2 diabetes among Koreans: A 12-year follow up of the Korean Genome and Epidemiology Study | 김대중, 김혜진, 이관우, 조남한, 한승진 |
| 2011 | | Intake of brown rice lees reduces waist circumference and improves metabolic parameters in type 2 diabetes. | 김대중, 김혜진, 이관우, 이민석, 한승진 |
| 2011 | | Involvement of visfatin in palmitate-induced upregulation of inflammatory cytokines in hepatocytes. | 강엽, 김대중, 김혜진, 이관우, 최용준, 한승진 |
| 2015 | | Lobeglitazone and pioglitazone as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, parallel-group, active-controlled, phase III clinical trial with a 28-week extension. | 이관우 |
| 2018 | | Long-term patterns of fasting blood glucose levels and pancreatic cancer incidence | 하경화 |
| 2015 | | Paradoxical Associations of Insulin Resistance With Total and Cardiovascular Mortality in Humans. | 김대중 |
| 2015 | | Performance of HbA1c for the prediction of diabetes in a rural community in Korea. | 김대중 |
| 2005 | | Predictive clinical parameters for therapeutic efficacy of rosiglitazone in Korean type 2 diabetes mellitus. | 김대중 |
| 2006 | | Prevalence of the metabolic syndrome among Korean adults according to the criteria of the International Diabetes Federation. | 김대중 |
| 2015 | | PROPIT: A PROspective comparative clinical study evaluating the efficacy and safety of PITavastatin in patients with metabolic syndrome. | 김대중 |
| 2020 | | Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study | 김대중 |
| 2021 | | Safety and effectiveness of linagliptin in Korean patients with type 2 diabetes: A postmarketing surveillance study | 정윤석 |
| 2014 | | Serum magnesium level is associated with type 2 diabetes in women with a history of gestational diabetes mellitus: the Korea National Diabetes Program study. | 이관우 |
| 2013 | | Sleep duration and glycemic control in patients with diabetes mellitus: Korea National Health and Nutrition Examination Survey 2007-2010. | 김대중, 이관우, 정윤석, 최용준, 한승진 |
| 2016 | | Statins and risk for new-onset diabetes mellitus: A real-world cohort study using a clinical research database | 박래웅, 신승수, 윤덕용, 임홍석, 최용준 |
| 2006 | | The association of total and differential white blood cell count with metabolic syndrome in type 2 diabetic patients. | 김혜진 |
| 2022 | | The Degree of Glycemic Control for the First Three Months Determines the Next Seven Years | 김대중, 이나미 |
| 2007 | | The diagnosis of diabetes mellitus in Korea: a pooled analysis of four community-based cohort studies. | 김대중 |
| 2006 | | The effects of Goami No. 2 rice, a natural fiber-rich rice, on body weight and lipid metabolism. | 김대중, 김연경, 이관우 |
| 2007 | | The increase in abdominal subcutaneous fat depot is an independent factor to determine the glycemic control after rosiglitazone treatment. | 김혜진 |
| 2006 | | The long-term effects of rosiglitazone on serum lipid concentrations and body weight. | 김혜진 |
| 2021 | | Time to reach target glycosylated hemoglobin is associated with long-term durable glycemic control and risk of Diabetic complications in patients with newly diagnosed Type 2 Diabetes mellitus: A 6-year observational study (Diabetes Metab J 2021;45:368-78) | 전자영 |
| 2012 | | β-Cell-protective effect of 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid as a glutamate dehydrogenase activator in db/db mice | 강엽, 김대중, 김혜진, 이관우, 한승진 |
